These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The physician, tranquilizers and control of nervousness. BROOKES RD Mo Med; 1960 Feb; 57():155-7. PubMed ID: 13804767 [No Abstract] [Full Text] [Related]
4. [NEUROLEPTICS AND TRANQUILIZERS]. RAJOTTE P Union Med Can; 1964 Mar; 93():320-1. PubMed ID: 14142347 [No Abstract] [Full Text] [Related]
5. [Clinical experiences with a new neuroleptic: thioridazine]. PINCHERLE M Arch Psicol Neurol Psichiatr; 1959; 20():357-71. PubMed ID: 14433029 [No Abstract] [Full Text] [Related]
7. [Psychopharmacological treatment of anxiety by methaminodiazepoxide]. MENDES JF; da SILVA F J Med (Oporto); 1962 Jan; 47():117-25. PubMed ID: 14472550 [No Abstract] [Full Text] [Related]
8. [Some implications of drug therapy of anxiety. (Note on the use of fluphenazine)]. PORTELA JM; SILVA IR; SILVA AR Hospital (Rio J); 1962 Mar; 61():551-60. PubMed ID: 14488055 [No Abstract] [Full Text] [Related]
10. Trifluoperazine in anxiety states. One year's clinical experience. SOUDER FR Antibiotic Med Clin Ther (New York); 1959 Dec; 6():711-4. PubMed ID: 13833001 [No Abstract] [Full Text] [Related]
11. The effect of amphenidone (Dornwal) in anxiety states: a multi-blind study. AZIMA H; ARTHURS D; SILVER A Am J Psychiatry; 1961 Aug; 118():159-60. PubMed ID: 13685432 [No Abstract] [Full Text] [Related]
12. Does chronic schizophrenia respond to a combination of a neuroleptic and an antidepressant? HORDERN A; SOMERVILLE DM; KRUPINSKI J J Nerv Ment Dis; 1962 Apr; 134():361-76. PubMed ID: 14448870 [No Abstract] [Full Text] [Related]
13. Captodiame in anxiety states in general practice. PENTNEY BH; BROTHERWOOD RW Practitioner; 1960 Aug; 185():218-21. PubMed ID: 14431646 [No Abstract] [Full Text] [Related]
14. [Contribution to the symptomatic analysis of anxiety with the help of methaminodiazepoxide therapy]. MICHAUX L; DUCHE DJ Ann Med Psychol (Paris); 1962 Feb; 120(1)():338-42. PubMed ID: 14473384 [No Abstract] [Full Text] [Related]
15. A clinical evaluation of fluphenazine. GRAY WD Int Rec Med; 1960 Jun; 173():375-9. PubMed ID: 13829130 [No Abstract] [Full Text] [Related]
17. [Therapeutic trials with thioridazine. Reflections on the "symptomatic treatment" of anxiety]. RAMEE F; GUILLERM ; BACIOCCHI ; GUILLOU ; MADEC Ann Med Psychol (Paris); 1962 Apr; 120(1)():803-11. PubMed ID: 14490099 [No Abstract] [Full Text] [Related]
18. A pilot study of P-2647, a new benzoquinolizine derivative employed as a psychotherapeutic agent in 44 cases of overt anxiety. SMITH ME Am J Psychiatry; 1962 Apr; 118():937-8. PubMed ID: 13914354 [No Abstract] [Full Text] [Related]
19. Preliminary human bioassay of benzquinamide in ambulatory psychoneurotics. SHULKIN MW; DYKYJ R; BODI T; LIM M; SIEGLER PE; MAPP Y; NODINE JH Curr Ther Res Clin Exp; 1962 May; 4():285-94. PubMed ID: 13912381 [No Abstract] [Full Text] [Related]
20. New psychotherapeutic agent, chlordiazepoxide. Use in treatment of anxiety states and related symptoms. TOBIN JM; LEWIS ND JAMA; 1960 Nov; 174():1242-9. PubMed ID: 13777123 [No Abstract] [Full Text] [Related] [Next] [New Search]